- Home
- Companies
- LentiKat`s a.s.
- Services
- Pharmaceutical & Food Industry
Pharmaceutical & Food Industry
Lentikats Biotechnology finds its applications within pharmaceutical and food industry during the intensification of enzyme- or bacteria-driven biotechnological processes. The immobilisation of such catalytic biomass leads to a production of robust biocatalysts, characterised by a high reaction activity, mechanical stability and easy separability from the reaction media. Mild conditions during the production procedure allow the immobilisation of any enzyme or bacteria, while allowing maintenance of the high initial reactivity of the biomass.
Advantages
- possible repeated use of the immobilised biomass,
- high stability of encapsulated biomaterial and matrix,
- easy separation,
- high reaction rates,
- lower risk of contamination,
- easy process control,
- possible integration into existing processes,
- minimum production of by- and waste products,
- possible encapsulation of any enzyme or bacteria,
- significant operational and investment costs savings.
Industrial Encapsulation
Milk and whey processing
- Production of lactose-free milk
- Production of D-galactose
- Production of galactooligosacharides
Sugar processing and syrup-production processes
- Production of invert sugar
- Production of glucose-fructose syrups
- Production of glucose syrups
Organic acids-making processes
- Production of lactic acid
- Production of gluconic acid (under development)
- Production of itaconic acid (under development)
Production of the semi-synthetic antibiotic precursors
- 6-aminopenicillin acid (6-APA)
- 7-aminodeacetoxycephalosporic acid (7-ADCA)
Production of antibiotics (under development)
- Amoxicilin
- Ampicilin
- Cephalosporin
- Cefalexin
Other applications (under development)
- Production of 1, 3 – propandiol
- Production of dihydroxyaceton
Industrial encapsulation
Industrial encapsulation is derived from the versatile character of Lentikats Biotechnology and its potential to immobilise any enzyme or a cell, in the form of whole or disintegrated cells, free and pre-immobilised enzymes. LentiKat`s a.s. addresses its potential customers with the offer to encapsulate a biomaterial of their choice, commercially available industrial preparations as well as their own modified microorganisms and recombinant proteins. High quality of services, speed of processing and discretion are integral parts of every offer.
Research & Development
In cooperation with leading research centers and companies LentiKat`s a.s. is constantly developing new products and applications of Lentikats Biotechnology. The company is currently involved in the following projects:
- Bionexgen Project – a multi-field interconnection between academic research and industrial practice, aimed to develop several new bio-transformation processes for production of specialty chemicals,
- development of multienzymatic biocatalysts for their application in elimination of persistant pollutants from the environment,
- encapsulation of stem cells,
- enhancement of enzyme characteristics by their modification and encapsulation into magnetic nanoparticles prior to their encapsulation into a PVA carrier,
- elimination of microbial contamination during biotechnological processes using silver nanoparticles.